JIANMIN PHARMACEUTICAL GROUP revenue for the last year amounted to 4.21 B CNY, the most of which — 4.16 B CNY — came from its highest performing source at the moment, Pharmaceutical Production, the year earlier bringing 3.56 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANMIN PHARMACEUTICAL GROUP 4.21 B CNY, and the year before that — 3.64 B CNY.